Loading
Everything OnCo dates to 1974: 16 entries, 8 landmarks, 5 journals founded, 2 approvals and 1 paper. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
16 dated entries in OnCo fall in 1974: 8 landmarks, 5 journals founded, 2 approvals and 1 paper.
Of those, 16 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Broad: sarcomas, lymphomas, leukaemias, breast, and other solid tumours
Disseminated gastric or pancreatic adenocarcinoma (with other agents)
The publication year on key paper records.
Stutman O. Science.
The history entries editors wrote on cancer records: the dated turning points of each disease.
Testicular germ cell tumours. Cure rates in metastatic disease jump from ~10% to ~60-70%.
Goblet cell adenocarcinoma of the appendix
Ewing sarcoma
Lip cancer
Plasma cell leukaemia
Inflammatory breast cancer
Localised anal squamous cell carcinoma (stage I to III)
Anal cancer (squamous cell carcinoma). Three patients with complete response to 5-FU, mitomycin and radiation; abdominoperineal resection abandoned as first treatment.
The founded year on journal records.
Elsevier
Cell Press (Elsevier)
Gan To Kagaku Ryohosha
Springer (Springer-Verlag)
Elsevier (W. B. Saunders)